From the six signature proteins (HLA-A, CFH, CD44, PTPRJ, HP, and CDH5), only CD44 has been previously associated with CRC prognosis in tumor specimens from 74 patients that were assayed by immunohistochemistry (Huh et al, 2009). Here, HP is linked to neoplasm.